Is Medincell SA halal to invest in?

According to Musaffa's Shariah screening methodology, Medincell SA (MEDCL.PA) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Medincell SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Medincell SA using these criteria to determine its compliance status.

Can Muslims buy shares of Medincell SA?

Muslim investors may consider investing in Medincell SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Medincell SA classified as NOT HALAL?

Musaffa determines the Shariah status of Medincell SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Medincell SA updated?

The Shariah compliance status of Medincell SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Medincell SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Medincell SA?

You can check the latest Shariah compliance status of Medincell SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Medincell SA MEDCL.PA

€28.01 €0.25 (0.89%) 1D

Last Updated: May 15, 12:00 AM·XPAR

MEDCL.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 14, 2026

Report Source: 2026 2nd Quarter Report

Analyst's Ratings for Medincell SA (MEDCL.PA)

Based on 17 analysts giving stock ratings to Medincell SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Medincell SA. Stock Analysis MEDCL.PA

France Health Care Small Cap Report: Q2, 2026

MedinCell SA is a pharmaceutical company, which engages in the development of injectable products in therapeutic areas. The company is headquartered in Jacou, Occitanie and currently employs 145 full-time employees. The company went IPO on 2018-10-08. The firm is focused on the development of therapeutic solutions with worldwide access. The firm works on both for-profit and non-profit projects, in collaboration with partners ranging from pharmaceutical corporations to physicians, from biotechnology firms to academics and foundations. Its range of products consists of three products in development phase: mdc-IRM, a subcutaneous injection in phase III clinical study for the treatment of schizophrenia; mdc-CWM, an intra-articular injection in phase II clinical study for the treatment of post-surgical pain and inflammation; mdc-TJK, a subcutaneous injection for the treatment of schizophrenia, as well as a number of other products that are in the research phase, such as mdc-WWM, which is a subcutaneous injection for contraception, and mdc-ELK, a subcutaneous injection for the treatment of depression, among others.

Key Statistics of Medincell SA (MEDCL.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€27.34€28.72

Today's Open

€28.26

Volume

38.75K

P/E Ratio (TTM)

52 Week Range

€15.00€39.68

Market Cap

880.35M

Avg. Volume

73.61K

Dividend Yield

Financial Metrics & Statements of Medincell SA (MEDCL.PA)

FAQ's for Medincell SA (MEDCL.PA)

According to Musaffa’s Shariah screening methodology, Medincell SA (MEDCL.PA) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.